According to previous research [19, 22], ANRIL could epigenetically regulate p15INK4B and p16INK4A in Cis by binding to PRC2, we examined whether ANRIL could regulate p15INK4B and p16INK4A in gastric cancer cells. This evidence concerns the gene CDKN2B and gastric cancer.